| Date | Title | Description | |
|---|---|---|---|
| 26 Jul 2023 | On buy-back programmes | The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program. | Download |
| 10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
| 10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
| 21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 13 May 2021 | Announcement of general shareholders’ meeting | Rovi releases the information related to its 2021 General Shareholders Meeting | Download |
| 06 Apr 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the first quarter of 2021 | Download |
| 24 Feb 2021 | Annual Corporate Governance Report | ROVI releases the 2020 Annual Corporate Governance Report | Download |
| 24 Feb 2021 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors | Download |
| 24 Feb 2021 | On business and financial situation | The company releases the press release related to 2020 financial results | Download |